Medication

FILE - In this June 15, 2018, file photo, pharmaceuticals are seen in North Andover, Mass. A government report says prices for prescription drugs edged down 1% last year, driven by declines for generics and slow growth for brand-name medications. (AP Photo/Elise Amendola, File)
1010 WINS Newsroom
December 05, 2019 - 4:02 pm
WASHINGTON (AP) — Prices for prescription drugs edged down by 1% last year, a rare result driven by declines for generics and slow, low growth in the cost of brand-name medications, the government said Thursday. Though modest, it was the first such price drop in 45 years, according to nonpartisan...
Read More
In this Nov. 22, 2019, photo, Charles Flagg, who is stricken with Alzheimer's disease, receives the contents of an intravenous bag while participating in a study on the drug Aducanumab at Butler Hospital in Providence, R.I. New results were released on the experimental medicine whose maker claims it can slow the decline of Alzheimer's disease, the most common form of dementia. (AP Photo/Charles Krupa)
1010 WINS Newsroom
December 05, 2019 - 3:20 pm
SAN DIEGO (AP) — A company that claims to have the first drug to slow mental decline from Alzheimer's disease made its case to scientists Thursday but left them sharply divided over whether there’s enough evidence of effectiveness for the medicine to warrant federal approval. Excitement and...
Read More
This undated photo provided by Acadia Pharmaceuticals Inc. shows a bottle of Nuplazid, a drug that was tested for treating psychosis related to dementia. If regulators agree, the drug could become the first treatment specifically for dementia-related psychosis and the first new medicine for Alzheimer's in nearly two decades. Results from a study on the drug were disclosed Wednesday, Dec. 4, 2019, at an Alzheimer's conference in San Diego. (Acadia Pharmaceuticals Inc. via AP)
1010 WINS Newsroom
December 04, 2019 - 8:53 pm
SAN DIEGO (AP) — A drug that curbs delusions in Parkinson's patients did the same for people with Alzheimer's disease and other forms of dementia in a study that was stopped early because the benefit seemed clear. If regulators agree, the drug could become the first treatment specifically for...
Read More
This undated photo provided by MIT/Langer Lab shows a star-shaped gastric resident dosage form of birth control that can be folded into a standard capsule and orally ingested. The dosage form resides in the stomach for up to a month where it releases the contraceptive drug.​ (Paramesh Karandikar/MIT/Langer Lab via AP)
1010 WINS Newsroom
December 04, 2019 - 2:05 pm
WASHINGTON (AP) — Birth control pills work great if women remember to take them every day but missing doses can mean a surprise pregnancy. Now scientists have figured out how to pack a month’s supply into one capsule. The trick: A tiny star-shaped gadget that unfolds in the stomach and gradually...
Read More
FILE - In this July 16, 2019, file photo, Health and Human Services Secretary Alex Azar pauses while speaking during a Cabinet meeting at the White House, in Washington. The government opened a new program Tuesday to provide an HIV prevention drug for free to people who need the protection but have no insurance to pay for it. (AP Photo/Alex Brandon, File)
1010 WINS Newsroom
December 03, 2019 - 9:31 am
WASHINGTON (AP) — The government launched a new program on Tuesday to provide an HIV prevention drug for free to people who need the protection but have no insurance to pay for it. Taking certain anti-HIV drugs every day dramatically reduces the chances that someone who is still healthy becomes...
Read More
FILE - This undated photo provided by the Centers for Disease Control and Prevention shows a scanning electron micrograph of multiple round bumps of the HIV-1 virus on a cell surface. When newborns are infected with HIV, a new study suggests starting treatment right away is better than waiting just a few weeks to months. Harvard researchers found the earliest-treated babies had a much smaller “reservoir” of HIV still lurking in their bodies, and a better functioning immune system. (Cynthia Goldsmith/Centers for Disease Control and Prevention via AP)
1010 WINS Newsroom
November 27, 2019 - 2:04 pm
WASHINGTON (AP) — When babies are born with HIV, starting treatment within hours to days is better than waiting even the few weeks to months that’s the norm in many countries, researchers reported Wednesday. The findings, from a small but unique study in Botswana, could influence care in Africa and...
Read More
1010 WINS Newsroom
November 26, 2019 - 2:33 pm
In a story Nov. 24, The Associated Press reported that an artificial intelligence program featuring a talking image of the Greek philosopher Aristotle is starting to help University of Southern California students cope with stress. The program’s designers recently removed that image based on...
Read More
1010 WINS Newsroom
November 24, 2019 - 5:06 pm
Swiss pharmaceutical company Novartis has reached a deal to buy cholesterol drugmaker The Medicines Co. for $9.7 billion. Novartis will pay $85 per share for the New Jersey biotech company, a sharp increase over The Medicine Co.’s Friday closing price of $68.55 per share. The deal is worth $9.7...
Read More
FILE - In this Nov. 8, 2018 file photo, the U.S. Medicare Handbook is photographed in Washington. Medicare’s new prescription drug plan finder has a glitch that can steer unwitting seniors to coverage that costs much more than they need to pay. (AP Photo/Pablo Martinez Monsivais)
1010 WINS Newsroom
November 21, 2019 - 5:06 pm
WASHINGTON (AP) — Medicare’s revamped prescription plan finder can steer unwitting seniors to coverage that costs much more than they need to pay, according to people who help with sign-ups as well as program experts. Serving some 60 million Medicare recipients, the plan finder is the most commonly...
Read More
FILE - This May 26, 2009 file photo shows a printout from an electrocardiogram machine in Missouri. Doctors are reporting that novel drugs may offer fresh ways to reduce heart risks beyond the usual medicines to lower cholesterol and blood pressure. One new study found that heart attack survivors benefited from a medicine long used to treat gout. Gene-targeting medicines also showed promise in studies discussed Monday, Nov. 18, 2019, at an American Heart Association conference in Philadelphia. (AP Photo/Jeff Roberson)
1010 WINS Newsroom
November 18, 2019 - 3:26 pm
PHILADELPHIA (AP) — Novel drugs may offer fresh ways to reduce heart risks beyond the usual medicines to lower cholesterol and blood pressure. One new study found that heart attack survivors benefited from a medicine long used to treat gout. Several experimental drugs also showed early promise for...
Read More

Pages